• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT TOTAL HCG (THCG)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT TOTAL HCG (THCG) Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/07/2019
Event Type  malfunction  
Manufacturer Narrative
The customer observed that the discordant result was reported two seconds after a diluted sample with a value greater than 135,000miu/ml.A siemens field service engineer (fse) was sent to the customer site for system inspection.The fse performed decontamination of the lines of acid, base and wash1 with h2o2 10%.After decontamination and daily maintenance, performance monitoring with controls was performed.The alignments of probes were verified.Dirt accumulated in stations 3 and 4 and in their probes was identified.The stations were cleaned.Siemens healthcare diagnostics is investigating.The ifu states in the interpretation of results section: "interpretation of results results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." the ifu states in the limitations section: "all in vitro assays can generate erroneous results, both clinically false positive results (test results suggesting a condition that is absent) and clinically false negative results (test results failing to identify a condition that is present).If an aberrant or abnormal result, as defined by the laboratory protocol, occurs, laboratory personnel should first make certain that the system is performing and is operated and maintained in accordance with the product labeling.The user should then follow the laboratory protocol for advising the clinician of a result that appears to have deviated from the norms established by the laboratory.Test results alone are not diagnoses of medical conditions.For example, low titer elevations of hcg can occur in normal non-pregnant subjects.A physician's diagnosis involves evaluation of the test result in conjunction with, and in the context of, the patient's medical history, physical examination, and other test results-sometimes in consultation with other medical experts.".
 
Event Description
A false positive advia centaur xpt total hcg result was obtained on a patient sample.The patient sample was repeated on the same instrument and the result was negative.The same sample was repeated again on the advia centaur xp and the result was negative.A corrected report was issued.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the discordant total hcg result.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2019-00122 on june 28, 2019.07/19/2019 additional information: siemens reviewed the event data and service report.The customer service engineer (cse) was dispatched on site to troubleshoot the issue.According to the service report, the cse noticed "dirt" accumulation at the rinse station 3 and 4.The cse proceeded to clean the rinse stations, and their probes.The cse further performed daily maintenance activity and a full system decontamination with h2o2 10% in the fluidic lines of acid, base and wash1.Verified instrument performance and controls and no further issues found.Based on the information provided, the probable cause was due to contamination of the instrument since after a full system decontamination and performing daily maintenance, the issue was resolved.The cse also found "dirt" accumulation at the rinse station which is evidence that proper maintenance was not followed.The operator should perform "clean probe rinse stations" activity in order to "clean the rinse station for the three reagent probes and the ancillary probe when you can see pragmatic particles on the rinse stations." as per "advia centaur xpt as-needed maintenance instruction".There is also no evidence of a product nonconformance since the service done is routine troubleshooting.The instrument is performing within specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XPT TOTAL HCG (THCG)
Type of Device
TOTAL HCG
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key8743721
MDR Text Key209597804
Report Number1219913-2019-00122
Device Sequence Number1
Product Code JHI
UDI-Device Identifier00630414505176
UDI-Public00630414505176
Combination Product (y/n)N
PMA/PMN Number
K925277
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 07/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/16/2019
Device Model NumberN/A
Device Catalogue Number10308985
Device Lot Number31956305
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/12/2019
Initial Date FDA Received06/28/2019
Supplement Dates Manufacturer Received07/19/2019
Supplement Dates FDA Received07/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age17 YR
-
-